Title |
Epithelial Mesenchymal Transition: a double‐edged sword
|
---|---|
Published in |
Clinical and Translational Medicine, April 2015
|
DOI | 10.1186/s40169-015-0055-4 |
Pubmed ID | |
Authors |
Guislaine Barriere, Pietro Fici, Giulia Gallerani, Francesco Fabbri, Michel Rigaud |
Abstract |
Epithelial mesenchymal transition (EMT) is a physiological process necessary to normal embryologic development. However in genesis of pathological situations, this transition can be perverted and signaling pathways have different regulations from those of normal physiology. In cancer invasion, such a mechanism leads to generation of circulating tumor cells. Epithelial cancer cells become motile mesenchymal cells able to shed from the primary tumor and enter in the blood circulation. This is the major part of the invasive way of cancer. EMT is also implicated in chronic diseases like fibrosis and particularly renal fibrosis. In adult organisms, healing is based on EMT which is beneficial to repair wounds even if it can sometimes exceed its goal and elicit fibrosis. In this review, we delineate the clinical significance of EMT in both physiological and pathological circumstances. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Poland | 1 | <1% |
Italy | 1 | <1% |
Unknown | 150 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 34 | 22% |
Student > Bachelor | 26 | 17% |
Student > Master | 19 | 13% |
Researcher | 15 | 10% |
Student > Doctoral Student | 9 | 6% |
Other | 23 | 15% |
Unknown | 26 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 42 | 28% |
Agricultural and Biological Sciences | 32 | 21% |
Medicine and Dentistry | 22 | 14% |
Immunology and Microbiology | 6 | 4% |
Engineering | 6 | 4% |
Other | 9 | 6% |
Unknown | 35 | 23% |